Quest Diagnostics (DGX)
Quest Diagnostics Statistics
Share Statistics
Quest Diagnostics has 111.61M shares outstanding. The number of shares has increased by 0.82% in one year.
| Shares Outstanding | 111.61M |
| Shares Change (YoY) | 0.82% |
| Shares Change (QoQ) | 0.27% |
| Owned by Institutions (%) | 85.71% |
| Shares Floating | 111.04M |
| Failed to Deliver (FTD) Shares | 6 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 2.27M, so 2.03% of the outstanding shares have been sold short.
| Short Interest | 2.27M |
| Short % of Shares Out | 2.03% |
| Short % of Float | 2.04% |
| Short Ratio (days to cover) | 3.15 |
Valuation Ratios
The PE ratio is 19.23 and the forward PE ratio is 16.17. Quest Diagnostics's PEG ratio is 6.95.
| PE Ratio | 19.23 |
| Forward PE | 16.17 |
| PS Ratio | 1.7 |
| Forward PS | 1.6 |
| PB Ratio | 2.47 |
| P/FCF Ratio | 18.42 |
| PEG Ratio | 6.95 |
Enterprise Valuation
Quest Diagnostics has an Enterprise Value (EV) of 20.13B.
| EV / Earnings | 23.11 |
| EV / Sales | 2.04 |
| EV / EBITDA | 14.95 |
| EV / EBIT | 14.95 |
| EV / FCF | 22.14 |
Financial Position
The company has a current ratio of 1.1, with a Debt / Equity ratio of 1.02.
| Current Ratio | 1.1 |
| Quick Ratio | 1.02 |
| Debt / Equity | 1.02 |
| Total Debt / Capitalization | 50.54 |
| Cash Flow / Debt | 0.19 |
| Interest Coverage | -6.7 |
Financial Efficiency
Return on equity (ROE) is 0.13% and return on capital (ROIC) is 7.48%.
| Return on Equity (ROE) | 0.13% |
| Return on Assets (ROA) | 0.05% |
| Return on Capital (ROIC) | 7.48% |
| Revenue Per Employee | 179.49K |
| Profits Per Employee | 15.84K |
| Employee Count | 55.00K |
| Asset Turnover | 0.61 |
| Inventory Turnover | 35.1 |
Taxes
| Income Tax | 273.00M |
| Effective Tax Rate | 0.23 |
Stock Price Statistics
The stock price has increased by 35.86% in the last 52 weeks. The beta is 0.91, so Quest Diagnostics's price volatility has been higher than the market average.
| Beta | 0.91 |
| 52-Week Price Change | 35.86% |
| 50-Day Moving Average | 157.09 |
| 200-Day Moving Average | 150.88 |
| Relative Strength Index (RSI) | 70.16 |
| Average Volume (20 Days) | 917.00K |
Income Statement
In the last 12 months, Quest Diagnostics had revenue of 9.87B and earned 871.00M in profits. Earnings per share was 7.8.
| Revenue | 9.87B |
| Gross Profit | 3.27B |
| Operating Income | 1.35B |
| Net Income | 871.00M |
| EBITDA | 1.35B |
| EBIT | 1.35B |
| Earnings Per Share (EPS) | 7.8 |
Balance Sheet
The company has 549.00M in cash and 6.92B in debt, giving a net cash position of -6.38B.
| Cash & Cash Equivalents | 549.00M |
| Total Debt | 6.92B |
| Net Cash | -6.38B |
| Retained Earnings | 9.36B |
| Total Assets | 16.15B |
| Working Capital | 223.00M |
Cash Flow
In the last 12 months, operating cash flow was 1.33B and capital expenditures -425.00M, giving a free cash flow of 909.00M.
| Operating Cash Flow | 1.33B |
| Capital Expenditures | -425.00M |
| Free Cash Flow | 909.00M |
| FCF Per Share | 8.19 |
Margins
Gross margin is 33.15%, with operating and profit margins of 13.63% and 8.82%.
| Gross Margin | 33.15% |
| Operating Margin | 13.63% |
| Pretax Margin | 11.9% |
| Profit Margin | 8.82% |
| EBITDA Margin | 13.63% |
| EBIT Margin | 13.63% |
| FCF Margin | 9.21% |
Dividends & Yields
DGX pays an annual dividend of $3.2, which amounts to a dividend yield of 1.86%.
| Dividend Per Share | $3.20 |
| Dividend Yield | 1.86% |
| Dividend Growth (YoY) | 12.68% |
| Payout Ratio | 41.61% |
| Earnings Yield | 4.53% |
| FCF Yield | 4.73% |
Analyst Forecast
The average price target for DGX is $180, which is 4.5% higher than the current price. The consensus rating is "Hold".
| Price Target | $180 |
| Price Target Difference | 4.5% |
| Analyst Consensus | Hold |
| Analyst Count | 13 |
Stock Splits
The last stock split was on Jun 21, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 21, 2005 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 2.97 |
| Piotroski F-Score | 6 |